Chromium
Active ingredient
Sold as Nicotinamide · ADDNUTRIV · Pancreas Liquescence · MICRO CR
- Drug class
- -
- Availability
- Prescription and OTC
- Routes
- Oral, Intravenous
- Markets covered
- 2
- Products on record
- 4
- FDA reports (12 mo)
- 6
Overview
Plain-language summary, compiled from the cited regulatory records
Chromium is an ingredient used in homeopathic preparations. It is not assigned to a specific drug class. [1]
This product is indicated to provide potentized homeo-nutritional support of the pancreas. [1] Claims for this use are based on traditional homeopathic practice and have not been evaluated by regulatory agencies. [1] Chromium is available under various brand names, including Nicotinamide and Pancreas Liquescence. [1]
In the past 12 months, there have been 6 adverse event reports associated with this ingredient. [2] The most frequently reported adverse events include amaurosis fugax, increased blood cholesterol, decreased blood creatinine, bronchospasm, and dental caries. [2]
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | February 13, 2025 |
| CA Canada | Health Canada | 2 | December 5, 2025 |
USUnited States· FDA
2 products
Uses
† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
How to take
CACanada· Health Canada
2 products
Uses
Addnutriv™, Trace Elements for Injection, is indicated as part of intravenous solutions for parenteral nutrition to meet basal to moderately increased requirements of the trace elements chromium, copper, iodide, iron, fluoride, manganese, molybdenum, selenium, and zinc in adults.
It prevents depletion of endogenous stores of these elements and development of subsequent deficiency symptoms. 1 Pediatrics Pediatrics: No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use.
2 Geriatrics Geriatrics (> 65 years of age): Evidence from clinical studies and experience suggests that Addnutriv can be used in geriatric population, see Warning section.
How to take
Sources & citations
- [1]FDA DailyMed · 06300339-b068-46… · revised March 27, 2023 [PDF]
- [2]Health Canada (DPD) · 02497697 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.